Researchers identified 5 distinct clusters for disease exacerbation that went beyond disease labels for both asthma and chronic obstructive pulmonary disease (COPD). When examining common factors for ...
Artificial intelligence (AI) and natural language processing tools can build an algorithm that identifies patients with chronic obstructive pulmonary disease (COPD) at risk for exacerbations, ...
Treatment with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) compared with FF/VI or UMEC/VI reduced exacerbation-related costs associated with chronic ...
Chronic obstructive pulmonary disease (COPD) is the name for a group of chronic conditions, including emphysema and chronic bronchitis, that make it difficult to breathe. COPD flare-ups are called ...
Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results